Interventional radiology: The corner-stone of breast management  by Plantade, R.
Diagnostic and Interventional Imaging (2013) 94, 575—591
REVIEW / Breast imaging
Interventional  radiology:  The  corner-stone  of  breast
management
R.  Plantade
854,  route  de  Bénesse-Maremne,  40150  Angresse,  France
KEYWORDS
Breast  cancer;
Core  needle  biopsies;
Large  core  biopsies;
Abstract  There  has  been  considerable  progress  in  recent  years  in  both  diagnostic  and  inter-
ventional breast  imaging.  Percutaneous  procedures  improve  multidisciplinary  management  and
provide patients  with  better  information.  Biopsies  allow  precise  and  accurate  diagnosis  avoid-
ing repeated  examinations  causing  the  patient  anxiety  and  unnecessary  surgical  procedures.Preoperative
marking;
Tumor  destruction
Preoperative  marking  guides  surgery,  thus  limiting  insufﬁcient  or  excessive  ablation.  Tumors’
destruction  can  sometimes  replace  surgery  in  older  or  frail  women.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Introduction
The  incidence  of  breast  cancer  is  progressing  at  a regular  rate  in  industrialized  countries:
it  reached  53,000  new  cases  per  year  in  France  in  2011  and  was  the  cause  of  11,400  deaths
[1].  It  is  the  most  common  cancer  in  women  and  the  primary  cause  of  mortality  between
40  and  55  years  of  age.  Its  prognosis  is  directly  correlated  with  the  stage  of  development
at  the  time  of  diagnosis.  Mammographic  screening  is  thought  to  result  in  a  25%  reduction  in
the  risk  of  mortality  due  to  breast  cancer  [2,3].  Extending  it  would  help  detect  subclinical
abnormalities,  for  which  various  percutaneous  procedures  controlled  by  imaging  have  been
developed  over  the  last  20  years  to  optimize  therapeutic  management.
Abbreviations: EUSOBI, EUropean SOciety of Breast Imaging; MRI, Magnetic Resonance Imaging; ADH, Atypical Ductal Hyperplasia; DCIS,
Ductal Carcinoma In Situ; HAS, Haute Autorité de santé (French National Authority for Health); BI-RADS, Breast Imaging Reporting And
Data System; ANAES, Agence Nationale d’Accréditation et d’Évaluation en Santé (French National Agency for Healthcare Accreditation and
Evaluation); INCa, Institut National du Cancer (French National Cancer Institute); G, Gauge; LIN, Lobular In situ Neoplasia; ROLL, Radioguided
Occult Lesion Localisation; SNOLL, Sentinel Node Occult Lesion Localisation.
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he interventional environment and
rerequisites
oncerning  all  areas  of  medical  imaging,  interventional  radi-
logy  has  become  essential  in  the  diagnostic  and  therapeutic
anagement  of  various  organs.  It  requires  speciﬁc  initial
raining  followed  by  regular  practice.  The  equipment  and
ctions  can  be  mastered  by  learning  on  phantoms,  without
tress  or  danger  for  the  patient.  The  European  Society  of
reast  Imaging  (EUSOBI)  has  published  recommendations  for
nterventional  breast  imaging  [4]:
training  necessitates  at  least  20  procedures  per  type
of  guidance,  with  histological  veriﬁcation  and  check-
ing  by  a  specialist,  before  being  able  to  work
alone;
to  maintain  a  sufﬁcient  degree  of  competence  subse-
quently,  25  procedures  per  year  are  considered  to  be
necessary  [4,5]  http://www.ear.online.org.
In  addition,  for  MRI  procedures,  regular  practice  in
reast  MRI  is  required,  initial  training  of  three  MRI  pro-
edures  then  maintenance  of  the  skill  with  10  procedures
er  site  and  per  year  [6,7].  Depending  on  the  degree
f  technical  difﬁculty  and  risk,  the  French  interventional
adiology  federation  (Fédération  de  radiologie  intervention-
elle)  has  classiﬁed  the  various  interventional  procedures
n  three  levels,  from  one  (minor)  to  three  (major).  With
he  exception  of  tumor  destruction  (level  2)  interventional
reast  procedures  are  considered  to  be  ‘minor’  (level  1)
nd  are  carried  out  in  an  outpatient  department  in  a
imple  medicalised  environment  (Fig.  1).  The  use  of  an
nterventional  room  and  access  to  an  anaesthetist  or  an
perating  theatre  is  not  necessary.  It  is  recommended  that
 deﬁbrillator  should  be  available  if  an  electric  current
s  used  (large  core  en-bloc  using  radiofrequency  or  tumor
estruction).
For  biopsies  and  destruction  there  is  a  signiﬁcant  risk
f  bleeding,  which  means  certain  precautions  must  be
aken:  cyclooxygenase  inhibiting  antiaggregants  (Aspirin®)
nd  adenosine  diphosphate  receptor  inhibitors  (Plavix®,
iclid®,  Eﬁent®)  can  be  continued.
igure 1. a: ultrasonography room not exclusively for interventional
echnical (height adjustable examination bed, strong, centered lighting)
rocedures with its digital stereotactic table.
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In  the  case  of  antivitamin  K  treatment,  there  should  be
rior  consultation  with  a  cardiologist  or  anaesthetist  to  dis-
uss  the  possibility  of  using  a low  molecular  weight  heparin
elay.  Otherwise,  a  decision  should  be  taken  based  on  the
nternational  normalized  ratio  (INR,  derived  from  the  pro-
hrombin  concentration):  the  haemorrhagic  risk  is  minor
elow  two  and  major  above  three.
Management  is  best  provided  by  specialists  forming  a
ultidisciplinary  breast  team  [8].
Before  any  procedure,  the  entire  ﬁle  should  be  reviewed
nd  validated  by  the  radiologist  responsible  for  performing
t,  who  should:
look  for  any  anticoagulant  treatment,  allergy  or  serocon-
version;
check  the  indication  and  technique  against  a  validated
reference  system,  possibly  during  a  consultation  or  a  mul-
tidisciplinary  consultative  meeting  (biopsies,  ablation  or
tumor  destruction)  [9,10].
Simple,  intelligible  and  honest  information  should  be
iven  to  the  patient  concerning  the  procedure,  its  limita-
ions  and  risks  (article  35  of  the  French  Code  of  Deontology,
995).  Her  freely  given  informed  consent  must  be  obtained
nd  noted  in  the  ﬁle  [9].
A  written  protocol  which  is  systematically  applied  during
he  procedure  will  limit  undesirable  events.  The  check-list
ets  out  all  the  points  which  must  be  veriﬁed:
before  the  procedure:  identity  of  the  patient,  validation
of  the  procedure,  topography  of  the  lesion,  compliance
with  contraindications,  veriﬁcation  of  the  equipment,
preliminary  identiﬁcation  of  vials;
and  after  the  procedure:  traceability  of  the  disposable
material  (Fig.  2),  specimen  identiﬁcation  and  information
forms,  report  of  the  irradiation  delivered  and  any  inci-
dents,  recording  of  the  images,  provision  to  the  patient
of  an  information  sheet  and  an  appointment  for  learning
the  results. procedures but which allows them to be performed under good
 and aseptic conditions; b: room reserved for interventional breast
The  patient  and  radiologist  must  be  comfortably  installed
ith  the  examination  couch  correctly  adjusted  to  a  height
hat  avoids  any  fatigue  or  poor  position  and  allows  easy
ontrol  of  the  ﬁeld  of  intervention  and  the  screen  (Fig.  3).
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Figure 2. Label glued onto the bag of any disposable material
stating its technical characteristics (length, caliber) and its trace-
Figure 3. Installation for an ultrasound-guided vacuum biopsy.
The radiologist is installed comfortably and can, without turning,
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ciﬁcation  clusters  and  clips.  For  preoperative  locating
examinations,  guidance  may  be  ‘free-hand’  (the  skin  entryability (brand, description, batch no, expiry date).
Strict  asepsis  rules  must  be  observed  throughout  the  pro-
cedure,  in  particular  for  preoperative  marking:  disinfection
chain,  gloves  and  sterile  material,  waste  elimination  circuit
(Figs.  3  and  4).
Local  anaesthesia  is  often  necessary  depending  on  the
type  of  procedure,  sometimes  combined  with  light  preme-
dication.  There  must  be  compliance  with  contraindications
and  cumulative  doses  of  anaesthetic  and  any  associated
adrenaline.  Where  there  is  allergy  to  aminoglycosides,  xylo-
caine  can  be  replaced  by  articaine,  and  where  there  is  an
allergy  to  the  preservative,  xylocaine  without  adrenaline
can  be  used.  Anaesthesia  must  above  all  concern  the  skin
and  avoid  masking  the  lesion.
Malaise  and  inopportune  movements  must  be  limited  by
providing  a  relaxed  environment,  continually  talking  to  the
patient,  not  displaying  the  instruments  and  working  rapidly.
p
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Figure 4. a: core biopsy tray; b: medical waste collectors of varying sontrol the ultrasound screen, the ultrasound probe, the biopsy
eedle and the patient.
At  the  end  of  the  procedure,  a  dressing  is  applied  and  ver-
al  and  written  instructions  given  to  the  patient  concerning
ealing  with  any  complications  and  how  she  will  be  told  the
esults  [9].
he various guidance methods
nterventional  breast  procedures  are  guided  by  the  clinical
xamination  or  imaging.  For  palpable  lesions,  clinical  guid-
nce  may  be  sufﬁcient  but  radiological  control  allows  more
recise  targeting  [11].
For  subclinical  lesions,  radiological  guidance  is  essential,
nd  several  different  criteria  affect  the  choice  of  type  of
maging  used:  rapidity,  cost,  irradiation,  better  visualization
f  the  abnormality,  availability  of  the  technique,  the  team’s
xperience  etc.  The  two  main  guidance  methods  used  are
ammography  and  ultrasound.
ammography
ammography  provides  optimal  visualization  of  microcal-oint  determined  by  distances  from  the  nipple),  with  a  grid
ith  holes  or  a  windowed  compression  paddle.  The  depth  (z)
ize and shape.
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Figure 5. Stereotactic guidance: the opacity is accurately tar-
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Feted using two of the three incidences (−15, 0 and +15◦).
s  then  optimized,  unlike  with  stereotactic  guidance  where
he  adjustment  is  made  on  images  which  are  non-orthogonal
o  the  needle  and  where  there  is  an  accordion  effect  during
ecompression  of  the  breast.
For  sampling  where  targeting  must  be  precise  in  the
rontal  plane  (x,  y),  stereotactic  guidance  is  necessary
Fig.  5):  it  is  performed  on  a  stereotactically  equipped
ammogram  machine  or  on  a  digital  radiological  table
peciﬁcally  for  interventional  breast  procedures  (Fig.  1b).
oth  are  equipped  with  a  speciﬁc  computer  program,  which
alculates  the  Cartesian  or  polar  coordinates  of  the  target
rom  two  or  three  images  (generally  at  0◦,  +15◦,  −15◦).
ltrasonography
his  guidance  method  is  particularly  suitable  for  nodules  and
s  preferred  whenever  possible.  Ultrasonography  is  readily
ccessible,  rapid,  inexpensive,  non-irradiating  and  performs
ery  well  due  to  the  development  of  high  frequency  linear
ensors  and  real-time  control  (Figs.  1a,  3,  6,  7).As  the  ultrasound  gel  could  alter  the  cells  it  should
referably  be  replaced  by  an  antiseptic  for  ﬁne  needle  biop-
ies  with  cytological  smearing.  The  skin  can  be  marked  to
S
u
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igure 7. Ultrasound-guided collection of samples with an oblique appigure 6. Ultrasound-guided ﬁne needle capillary biopsy with a
ertical approach.
how  the  position  of  the  probe  and  the  lesion,  for  anaesthe-
ia  purposes  and  for  inserting  the  needle.
Particularly  during  this  initial  phase,  the  position  of  the
eedle  relative  to  the  ultrasound  probe  should  be  checked
isually  rather  than  using  the  screen,  because  the  area
xplored  by  the  probe  is  narrow.  There  are  two  techniques
or  approaching  the  lesion:
perpendicular:  the  needle  crosses  the  skin  perpendicular
to  the  long  axis  of  the  probe  and  a  few  millimeters  away
from  it  (Fig.  6).  As  its  path  is  vertical,  only  the  extremity
is  visible  as  a  very  attenuating  echogenic  spot  (tip  echo).
This  technique  can  only  be  used  for  ﬁne  needle  aspiration
as  there  is  a  major  risk  of  pneumothorax  in  the  case  of
other  biopsies;
parallel:  the  needle  approaches  the  skin  parallel  to  the
long  axis  of  the  probe  and  10—20  mm  from  it  (Fig.  7).  It
is  visible  throughout  its  course,  which  appears  oblique  or
better  still,  horizontal.  Correct  positioning  of  the  needle
in  the  lesion  is  checked  by  turning  the  ultrasound  probe
through  90◦.
RI or CTlice  imaging  is  only  used  for  abnormalities  (=  contrast
ptake)  invisible  in  the  mammogram  and  ultrasound  image
20  to  80%).
roach. a: ﬁne needle biopsy; b: core needle biopsy.
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Performed  using  MRI,  vacuum  biopsy  has  proved  to  be
more  appropriate  than  markers  and  more  effective  than  core
biopsy,  with  a  failure  rate  of  less  than  10%  and  underestima-
tion  of  the  lesion  of  less  than  5%  for  ADH  and  less  than  3%
for  ISDC.
Nevertheless,  the  level  of  diagnostic  conﬁdence  is  still
lower  than  with  other  guidance  methods  because  of  the
limited  means  of  control.  These  procedures  require  speciﬁc
non-magnetic  equipment,  real  patient  participation,  and  a
decidedly  longer  examination  time  (Fig.  8).  The  indications
are  very  limited  and  at  present  there  is  no  speciﬁc  rating,
but  the  care  management  ﬁle  submitted  to  the  HAS  in  July
2009  is  being  evaluated  [7].
These  various  aspects  have  put  a  brake  on  the  develop-
ment  of  this  indispensable  technique,  but  availability  over
the  country  is  gradually  increasing.
Installing the patients
The  woman  is  seated  or  in  a  lateral  decubitus  position  for
add-on  stereotactic  guidance.  She  lies  in  the  dorsal  decubi-
tus  position  for  ultrasonic  or  CT  procedures,  and  in  ventral
decubitus  for  procedures  on  the  dedicated  table  or  with  MRI.
Samples
Indications
Percutaneous  biopsies  are  recommended  in  the  following
situations:
• lesion  which  is  probably  benign  (BI-RADS  3)  in  a  breast
cancer  staging  examination,  where  there  are  risk  factors,
or  discordant  images,  monitoring  difﬁculty  or  early  preg-
nancy;
• systematically  for  suspect  lesion  (BI-RADS  4);
• for  very  suspect  lesion  (BI-RADS  5)  with  a  strategic  objec-
tive.
These  international  recommendations  have  been
adopted  by  ANAES  then  taken  up  by  INCa  and  by  the
medical  imaging  good  practice  guide  [12—15].
Figure 8. MRI-guided large core biopsy: the patient is installed
prone with the breast held ﬁrmly in the open coil. The biopsy is
performed via a strict proﬁle lateral route.
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hat is the strategy?
xtemporaneous  examination  is  not  advised  for  microcalci-
cation  clusters  and  masses  of  less  than  1  cm.  It  should  not
e  requested  for  a  percutaneous  biopsy.
If  two  suspect  lesions  are  more  than  20  mm  apart,  both
ust  be  biopsied,  and  if  a  focus  is  extensive,  it  is  sometimes
ecessary  to  biopsy  two  sites  (depending  on  its  location,  the
ize  of  the  breast  and  the  caliber  of  the  needle):  this  helps
etermine  the  extent  of  the  surgical  procedure  (complete
r  partial  mastectomy).
If  a  sample  shows  the  lesion  to  be  invasive,  lymph  node
issection  will  be  performed.
If  another  sample  shows  lymph  node  involvement,  a  clas-
ic  lymph  node  dissection  of  the  ﬁrst  two  Berg  levels  will  be
equired;  a  sentinel  procedure  can  no  longer  be  envisaged.
hy biopsy a cancer seen by imaging (BI-RADS
)?
he  HAS  recommends  that  any  lesion  suspected  of  being
alignant  should  be  conﬁrmed  histologically  before  any
urgical  procedure,  with  the  objective  of  more  than  70%
f  cancers,  palpable  or  not,  being  diagnosed  cytologically
r  histologically  before  surgery  [4,8,16].  This  is  also  to
imit  the  number  of  unnecessary  surgical  procedures  (a
enign/malignant  ratio  of  less  than  1  and  if  possible  less
han  0.5)  and  the  number  of  surgical  procedures  required
a  successful  1st  surgical  ablation  in  at  least  95%  of  cases)
4,8].
Obtaining  a prior  diagnosis  of  malignancy  has  several
dvantages:
it  ofﬁcially  conﬁrms  this  diagnosis  and  informs  the  patient
so  that  she  can  accept  the  therapeutic  proposals  more
easily;
it  determines  the  initial  surgical  or  medical  treatment;
surgery  can  be  optimized  (incision,  volume  of  the  abla-
tion)  and  a single  procedure  performed  (immediate
reconstruction,  removal  of  microcalciﬁcations,  implanta-
tion  of  a  vascular  access  device);
chemotherapy  or  neoadjuvant  hormone  therapy  can  be
initiated;
a  protocol  for  detecting  the  sentinel  lymph  node  or  nodes
can  be  set  up;
organizational  limitations  can  be  considered.
But  this  must  not  delay  therapeutic  management  [16].
he  time  between  the  appointment  and  treatment  should
ot  exceed  1  month  [13].
he different types of samples
ytological  samples:  ﬁne  needle  biopsy
ine  needle  cytological  biopsy  is  a very  inexpensive  and  very
apid  procedure  that  requires  the  whole  team  to  be  greatly
xperienced,  in  particular  the  pathologist,  so  as  to  limit  the
umber  of  non-contributing  samples  [17,18]  (Table  1).  It  is
erformed  with  a  needle  measuring  less  than  1  mm  [18  to
7  Gauge  (G)]  alone  (capillary  technique)  (Figs.  6,  7a)  or
ttached  to  a syringe  (aspiration  technique).
The  needle  effects  back  and  forth  movements  rotating
bout  its  own  axis.  The  cells  are  detached  then  spread  onto
580  R.  Plantade
Table  1  Performance  of  the  various  sampling  methods.
Ultrasound  guidance  (opacities)  Stereotactic  guidance  (microcalciﬁcations)  Surgery
Fine  needle
biopsy
Core  biopsy  Vacuum
biopsy
Core  biopsy  Vacuum
biopsy
One-pass
en-bloc
excision
14  G  11  G  14  G  11  G  2  cm
Failures  0.1—2% 0—5% 0.5—22
(2.5) %
False-negatives  5—11  0—3.7%  0.1—1.4%  0.1—11%  0—6%
Insufﬁcient
material
0—12  3%  2%
Sensitivity  89—98  86—100
(97)  %
94.5—97%  70—84%  90.5—97%
Speciﬁcity  91—98  95—100%  98—100%  96—100%  98—100%
Underestimation  33%  0—6.2%  20%
Atypical  ductal
hyperplasia
0—100
(33)  %
0—50
(17.9)  %
18—100%  0—35  (19)  %  0—20  (12)
Ductal  carcinoma
in  situ
16—55%  7—38  (23)  %  16—44%  0—26
(12.5)  %
0—21  (7.5)  %
Results as % (): mean %.
a  slide  (dried  in  the  air  or  ﬁxed  with  lacquer)  or  placed  in
ﬁxing  ﬂuid  (monolayer  technique)  (Fig.  9).
They  are  less  numerous,  but  less  affected,  with  the  cap-
illary  technique.  Cytology  is  particularly  suitable  for  ﬂow
cytometry  analysis  (DNA  ploidy  and  S  phase)  and  hormonal
receptors  can  also  be  measured  if  there  are  sufﬁcient  cells.
False-positive  are  sometimes  encountered  in  ﬂorid
mastopathies.  Certain  quality  criteria  are  recommended  [4]:
• no  more  than  10%  of  the  ﬁne  needle  biopsies  should  be
inadequate  for  cancer,  and  if  possible  less  than  5%;
• an  adequate  ﬁne  needle  aspiration  sample  should  contain
at  least  ﬁve  aggregates  of  epithelial  cells,  with  at  least
ﬁve  cells  in  each.
However,  ﬁne  needle  biopsy  has  two  major  limitations:
• it  does  not  allow  a  distinction  to  be  made  between  a
carcinoma  in  situ  and  an  invasive  cancer;
• it  is  totally  unsuitable  for  exploring  microcalciﬁcations.
Figure 9. Rather abundant cell sample after ﬁne needle breast
biopsy.
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fistological  sampling:  core  biopsy
his  involves  taking  tissue  cylinders,  the  caliber  and  length
f  which  vary  depending  on  the  instruments  used  (Fig.  10).
iagnostic  performance  is  improved,  particularly  for  micro-
alciﬁcation  foci,  by  increasing  the  tissue  volume  taken,
hich  is  proportional  to  the  number  of  samples  and  the
aliber  of  the  needle  used  [19—27].
Unlike  a  ﬁne  needle  biopsy,  a  core  biopsy  requires  a  local
naesthetic  and  the  result  cannot  be  obtained  immediately
28,29].
Tolerance  is  generally  good  or  very  good  (>  95%)  [30].
Samples  must  be  handled  as  little  as  possible  and  with
are.  They  are  placed  at  best  in  separate  cassettes,  ﬁxed
formol,  AFA  etc.)  then  included  in  parafﬁn  at  60 ◦C.  After
ooling,  compact  blocks  are  available  which  may  then  be
ectioned  with  a  microtome.  The  sections  are  spread  out,
tained  and  studied  at  several  different  levels,  providing  all
he  information  necessary  for  management  of  a  tumor:  its
nvasive  character,  differentiation,  grade,  hormonal  recep-
ors,  immunological  or  genetic  markers.  False-positives  are
xceptional.
ore  needle  biopsy
ore  biopsy  ﬁrst  appeared  in  1989  in  the  United  States
nd  has  become  the  standard  technique  for  diagnosis  of
ammary  nodules.  They  are  automatic  guillotine  type  sys-
ems,  propelling  in  a  fraction  of  a  second  a  sharp  notched
eedle,  immediately  covered  by  a  cutting  cannula,  which
ections  the  tissue  fragment  and  closes  the  biopsy  chamber
Figs.  7b,  11).  To  recover  the  sample  the  needle  is  extracted
rom  the  breast  each  time.  The  equipment  used  is  not  very
xpensive  and  the  examination  lasts  about  15  minutes.Sensitivity  increases  with  the  cross-section  of  the  nee-
le  (1.2  mm  to  2.1  mm  =  18  to  14  G)  and  the  length  of  its
ourse  (10  to  22  mm):  the  rate  of  inadequate  results  falls
rom  19%  to  3%  on  moving  from  a  16/18  G  to  14  G,  and
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Figure 10. a: tissue samples 8, 10 and 14 G caliber (from L to R); b: 8, 10 and 14 G needles (from L to R).
ram o
; d: o
2
tFigure 11. Core biopsy. a: non-disposable automatic gun; b: diag
the very suspect deep nodule (BI-RADS 5) using ultrasound guidance
to the pectoral plane.
sensitivity  increases  from  84  to  99%  (for  opacities)  and  from
47  to  92%  (for  microcalciﬁcations)  on  increasing  from  one  to
ﬁve  cores  (Table  1).
The  recommendation  is  to  obtain  these  samples  with  an
automatic  gun  [11],  14  G  needles  and  a  length  of  course  of
w
ﬁ
[f the various successive phases; c: the needle is placed in front of
n ﬁring, the needle transﬁxes the nodule while remaining parallel
0  mm  [4,31]. The  number  of  samples  necessary  varies  with
he  type  of  image  but  above  all  it  is  their  representativeness,
hich  counts.  For  a  mass,  some  authors  recommend  at  least
ve  samples  but  for  others  two  biopsy  cores  are  adequate
19,32,33].
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Be  that  as  it  may,  sampling  is  systematically  partial,
hich  is  a  limitation  for  diagnosing  complex  lesions  (border
r  DCIS).
Some  authors  combine  cytology  and  histology  in  order  to
btain  an  immediate  diagnosis,  which  is  conﬁrmed  later,  the
istology  correcting  the  cytology’s  false-positives  [34].
arge  core  biopsies
he  caliber  of  the  needles  is  larger  and  the  samples  are  gen-
rally  more  numerous.  Due  to  the  larger  volume  of  tissue
aken,  vacuum  biopsies  are  the  technique  of  choice  for  ana-
yzing  microcalciﬁcation  clusters,  architectural  distortions
nd  MRI  procedures.
After  incision  of  the  skin,  the  cannula  is  inserted  into  the
reast  manually  or  by  ﬁring,  when  a  vacuum  assisted  system
s  used.  At  the  end  of  the  procedure,  it  is  best  to  apply  a
ompressive  dressing.  There  are  three  types  of  large  core
iopsies:
biopsy  without  aspiration:  a  stylet  crosses  the  lesion,  then
a  helix  (Spirotome®)  or  freezing  (Cassi®)  ﬁxes  the  lesion
onto  this  axis.  The  cutter  sections  a  cylinder  of  tissue  then
igure 12. Vacuum-assisted biopsy. a: diagram of a probe with a doubl
tereotactic table; c: with the Mammotome®, the samples are collectedR.  Plantade
the  receiving  needle  is  withdrawn  from  the  breast  so  that
the  core  can  be  recovered.  The  operation  is  repeated  as
often  as  necessary  for  the  required  number  of  samples.
These  two  systems  allowing  limited  but  less  costly  samp-
ling  are  not  widely  distributed  in  France,  particularly  not
for  the  breast;
vacuum  assisted  biopsy:  this  is  the  system  most  widely
used,  with  needles  ranging  from  7  to  12  G.  Vacuum  aspi-
ration  pulls  the  mammary  tissue  into  the  biopsy  window
then  the  rotary  cutter  sections  a  cylinder  of  tissue.  This
rises  through  the  interior  of  the  needle  due  to  aspira-
tion  and  is  recovered  manually  outside  of  the  breast
(Mammotome®),  or  stored  in  a receptacle  to  the  rear
of  the  device,  which  limits  the  number  of  manipula-
tions  required  and  shortens  the  length  of  the  procedure
(SenoRx®,  Suros®)  (Figs.  3,  8,  12—14).  A  series  of  sam-
ples  is  taken  therefore  with  the  device  left  in  place  in  the
breast.  Each  is  10  to  20  mm  long,  2  to  3  mm  in  diameter,
and  weighs  between  60  to  400  mg.  By  rotating  the  needle,
contiguous  samples  can  be  obtained  through  360◦. The
number  of  specimens  is  adapted  to  the  size  of  the  lesion
e aspiration system; b: the patient is installed prone on the special
 one by one, manually, outside of the breast.
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Figure 13. Stereotactic vacuum biopsy. a: sub-centimeter microcalciﬁcation cluster, indeterminate BI-RADS 4; b: the probe’s sampling
window is placed opposite the cluster; c: after taking a few centered samples, the cluster in no longer visible; d: microcalciﬁcations are
found on the radiograph of the specimens; e: after removing the probe, the cluster has disappeared, replaced by a gas-ﬁlled cavity.
Figure 14. The various phases of an ultrasound-guided vacuum biopsy. a: diagram of insertion of the probe under the nodule. The probe
is inserted with ultrasound guidance, along an oblique axis; b: diagram illustrating centering the biopsy window under the nodule. The
probe is placed under the nodule with the sampling window opposite it; c: diagram showing the progress of the rotary cutter. The cutter
has sampled the deep surface of the nodule.
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Figure 15. a: suspect cluster of amorphous microcalciﬁcations (BI-RADS 4); b: after vacuum biopsy, the cluster is replaced by a small
gas-ﬁlled cavity and a marker clip.
and  the  caliber  used  [9].  For  an  image  measuring  less  than
1  cm  (a  mass  or  focus),  the  biopsy  can  be  considered  as
representative  if  it  explores  at  least  50%  of  the  lesion  and
the  ideal  number  of  samples  with  a  needle  ≤  10  G  would
be  six  [35].  On  the  other  hand,  with  a  needle  ≥  11  G,  best
performance  would  be  obtained  with  12  samples  [35]. The
whole  procedure  lasts  about  30  minutes.  If  the  abnormal-
ity  shown  on  the  radiological  image  has  been  completely
ablated,  a  microclip  is  placed  for  possible  later  peropera-
tive  location  (Figs.  15  and  16)  [9].  ADH  is  underestimated
by  about  19%  and  DCIS  by  12%  (Table  1);
• BLES  biopsy  (Intact®):  the  wand  (a  probe)  has  a  larger  cal-
iber  and  therefore  necessitates  a  larger  skin  incision,  of
Figure 16. Preoperative marking after large core biopsy (DCIS).
The end of the metal wire is correctly situated in contact with the
clip on the two orthogonal mammographic images. a: frontal image;
b: proﬁle image.
10  mm  as  against  4  mm.  At  the  end  it  has  a  capture  basket
consisting  of  ﬁve  double  metal  supporting  elements  joined
by  a  distal  ﬁlament.  Three  basket  sizes  are  available  (12,
15  and  20  mm)  so  that  a  single  sample  of  respectively  1.1,
2.1  and  3  grams  can  be  collected.  The  end  of  the  wand
is  placed  in  front  of  the  radiological  image.  When  the
basket  expands,  radiofrequency  passes  through  the  ﬁla-
ment,  sectioning  and  coagulating  the  mammary  tissue.
After  withdrawing  the  wand,  the  sample  is  recovered  by
cutting  the  metal  supporting  elements  with  pincers.  Anal-
ysis  of  the  single  block  of  tissue  obtained  provides  a  better
picture  of  the  architecture  and  size  of  the  lesion  and  of
the  clear  ablation  margins  (Figs.  17  to  20).  Coagulation
artifacts  may  be  observed  at  the  edges  of  the  sample,
but  they  are  usually  less  than  a  millimeter  and  do  not
interfere  with  histological  interpretation.
On  the  other  hand,  the  risk  of  burning  related  to  the
radiofrequency  restricts  the  conditions  under  which  it  can
be  used:
Figure 17. BLES biopsy using stereotactic guidance: the sample
is in the 20 mm metal basket.
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Figure 18. Large core biopsy samples for the same 17 mm sclerosed pe
The margins have been invaded by benign proliferation; b: the ablation 
• the  breast  must  be  sufﬁciently  thick  (at  least  25  mm  when
compressed);
• the  distance  between  the  lesion  and  the  skin  or  muscle
must  be  at  least  6  mm;
• use  with  MRI,  the  presence  of  mammary  implants  or  a
pacemaker  is  contraindicated.
Underestimation  of  ADH  and  DCIS  is  considered  to  be
reduced  compared  with  vacuum  biopsies  [36,37]  (Table  1).
Tumor  ablation  is  considered  complete  with  a  clear  margin
of  at  least  1 mm  in  75%  of  cases  [38].
What should be done in practice?
If  the  radiological  image  is  isolated,  clearly  visible  and
accessible,  the  standard  technique  for  the  abnormalities
shown  below  should  be  the  guidance  methods  as  follows:
Figure 19. BLES biopsy sample (20 mm basket) for a suspect sub-
centimeter opacity (BI-RADS 4), which was a microinvasive 8 mm
intermediate grade DCIS invading the sample margins.
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was then completed using vacuum system.
for  masses:  ultrasound-guided  core  needle  biopsy  [39]
(Fig.  11);
for  microcalciﬁcation  foci  or  architectural  disorganization
[4]: stereotactic  large  core  biopsy  (Fig.  12);
for  large  areas  of  microcalciﬁcations  associated  with  an
ultrasound  nodule:  ultrasound-guided  core  biopsy;
for  cysts  or  lymphadenopathies  (axillary,  supra-  or  sub-
clavicular):  ultrasound-guided  ﬁne  needle  biopsy  (Fig.  6).
Percutaneous  ablation  of  a  nodule  by  ultrasound-guided
arge  core  biopsy  (Figs.  3,  14)  can  sometimes  be  discussed  if
 sample  of  it  has  previously  been  shown  to  be  benign.  The
ain  indications  are  microbiopsies  that  are  discordant  or
ave  contributed  nothing,  solitary  papillomas  with  no  atypia
Fig.  21)  and  secondarily,  benign  lymph  nodes  (if  the  patient
esires  ablation).
ontrol images
hatever  the  guidance  method,  images  are  taken  before,
uring  (with  the  needle  in  situ)  and  at  the  end  of  the  proce-
ure  [9].
For  clustered  microcalciﬁcations,  a  radiograph  of  the
iopsy  samples  is  essential  to  conﬁrm  that  they  have  been
orrectly  sampled:  the  calciﬁcations  must  be  visible  there
nd  resemble  the  calciﬁcations  targeted  [9,19,40].
In  addition,  two  orthogonal  mammography  images  should
e  taken  immediately,  or  when  the  results  are  given  to  the
atient,  to  assess  the  percentage  of  calciﬁcations  removed
nd/or  to  check  the  correct  positioning  of  any  clip  [9].
ost-biopsy management
 radiology/histology/clinical  comparison  is  essential  to
nsure  that  the  samples  are  representative.
If  the  results  are  benign  and  concordant,  it  is  advisable  to
esume  monitoring  appropriate  to  the  patient’s  level  of  risk.
RI-guided  biopsies  are  an  exception  because  their  degree
f  conﬁdence  is  lower:  a  control  MRI  is  recommended  after
 months  [9].
586  R.  Plantade
F rea w
a rocal
c oma.
n
r
•
•
•
F
b
wigure 20. BLES sample with a 20 mm basket, for a convergence a
 small well-centered spiculated opacity accompanied by a few mic
: on microscopic analyses, it was a 6 mm tubular inﬁltrating carcin
In  the  case  of  a  border  lesion,  surgical  revision  is  usually
ecessary,  particularly  in  the  following  situations  where  the
isk  of  underestimation  exceeds  15%  [41]:
small  tissue  volume  sampled  (core  needle  biopsy  or  few
samples  taken);
•
•
igure 21. Uniporous, serous nipple discharge. a: ultrasound showed w
y a vascular pedicle; b: this intraductal proliferation was totally present
ithout atypia. The base of the implantation was healthy. The dischargehich has been stable for more than 5 years; a: the radiograph shows
ciﬁcations; b: the macroscopic scirrhous appearance is concordant;
 The margins of the sample had been invaded.
extensive  radiological  image  (>  20  mm);
incomplete  disappearance  of  this  image  after  biopsy;
good  agreement  between  the  radiological  image  and  the
histological  lesion;
at-risk  context;
ell delimited parietal burgeoning of a proximal lactiferous duct fed
 on the 11 G vacuum-assisted biopsy, and was a dendritic papilloma
 disappeared after this percutaneous procedure.
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Figure 22. Stereotactic preoperative location on a table reserved for the purpose. a: insertion of a metal thread; b: injection of blue
stain; c: skin marking in the surgical position.
Figure 23. Preoperative marking: on the two orthogonal mammographic images, the wire (X) crosses the cluster and its end is situated
a few mm beyond it; a: frontal image; b: proﬁle image.
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severe  lobular  neoplasia:  LIN  2  >  2  foci;  pleomorphic  LIN  3
or  with  necrosis  or  in  a  signet  ring.
If  these  different  criteria  are  absent,  the  risk  of  underes-
imation  is  lower  (<  10%)  and  percutaneous  ablation  (Fig.  21)
r  close  monitoring  can  be  discussed  [4,42].
Finally,  for  carcinomas,  surgical  revision  is  essential
ecause  tumor  remains  can  persist,  even  if  the  radiological
bnormality  has  completely  disappeared  [43—48].
If  the  histological  result  conﬂicts  with  the  radiological
mage,  another  percutaneous  biopsy  or  surgery  is  necessary:
t  can  be  performed  with  the  same  equipment  if  all  the  qual-
ty  criteria  were  not  observed  initially,  but  if  this  is  not  the
ase  a  larger  caliber  sample  must  be  obtained  [4].
This  biopsy  will  also  be  necessary  if  the  lesion  has  not
een  sufﬁciently  sampled.
uality criteria and results
he  rates  of  false  negatives  and  underestimates  must  be
valuated  and  limited.  The  percentages  recommended  by
USOBI  are  [4]:
false  negative  for  cancer  on  percutaneous  biopsy:  <  2%
(acceptable  <  5%);
diagnosis  of  cancer  in  situ  on  biopsy,  classiﬁed  as  invasive
after  surgery:  <  5%  (acceptable  <  15%);
diagnosis  of  border  lesions  on  biopsy,  classed  as  invasive
cancer  after  surgery:  <  10%  (acceptable  <  25%).
Percutaneous  biopsies  thus  help  limit  the  number  of  sur-
ical  procedures  by  increasing  the  positive  predictive  value
f  surgery  (which  was  lower  than  50%  before  the  use  of  such
iopsies)  and  lowering  the  number  of  revisions  for  insufﬁ-
ient  margins  [49—56].
mplanting markers
arious  types  of  markers  are  implanted  by  the  radiologist,
s  a  guide  for  himself  or  for  the  surgeon.  Three  types  of
arkers  can  be  used  and  they  are  often  used  in  combination.
etal markers
he  clip
 clip  is  implanted  any  time  there  is  a  risk  that  the  radio-
ogical  image  will  not  be  clearly  visible  in  the  future,  i.e.:
before  or  during  neoadjuvant  chemotherapy;
after  a  biopsy  in  the  following  situations:
◦ difﬁcult  and  random  targeting,
◦ multiple  samples  taken  from  the  same  breast,
◦ complete  or  subtotal  ablation  of  the  abnormality
seen  in  the  radiological  image  by  large  core  biopsy
(Figs.  13,  15),
◦ image  of  less  than  5  mm  in  the  case  of  a  core  needle
biopsy,
◦ systematically  after  an  MRI-guided  biopsy.
The  intramammary  clip  is  a  marker  for  the  radiologistor  later  monitoring  or  for  possible  preoperative  guidance
Figs.  15  and  16).
Preoperative  marking  is  performed  in  the  24  hours  before
he  procedure  and  enables  accurate  and  reliable  surgery.
s
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he  wire  marker
his  is  a  wire,  which  may  or  may  not  be  repositionable,  the
xtremity  of  which  is  bent  (into  a  V,  X,  etc.)  to  limit  its
igration  (Figs.  16,  22a,  23).
The  term  ‘harpoon’  needs  to  be  replaced  by  synonyms,
hich  are  less  worrying  for  the  patient  (wire,  marker,
ointer  or  metal  guide).
Sometimes  several  markers  are  needed  to  delineate  a
arge  focus,  being  aware  that  tumorectomy  will  remove
he  block  of  tissue  from  the  skin  to  the  pectoral  muscle,
ncluding  the  lesion.  The  lateral  ablation  margins  need  to  be
arked  to  indicate  the  superior,  inferior,  medial  and  lateral
imits.
Certain  quality  criteria  must  be  observed:
the  distance  between  the  end  of  the  marker  and  the
lesion  should  not  exceed  10  mm,  in  at  least  80%  of  cases
(Figs.  16,  23) [8];
the  failure  rate  must  be  less  than  1%  [57].
Otherwise,  the  marker  is  repositioned  or  replaced  by
nother.
It  must  be  longer  than  the  lesion,  even  be  too  long,
ut  falling  short  of  it  must  be  completely  avoided.  Using
tereotaxy,  10  mm  can  be  easily  added  to  the  z  calcu-
ated  by  the  program  in  order  to  anticipate  the  accordion
ffect.
Placing  the  end  of  a  marker  (particularly  X  mark-
rs)  in  the  centre  of  a  focus  must  be  avoided,  as  the
athologist  could  damage  the  operative  specimen  when
xtracting  it.
njections
ntra  or  peritumoral  injections  are  only  possible  for  unifo-
al  lesions.  Only  a  very  small  quantity  is  injected  (0.2  mL),
ossibly  combined  with  an  X-ray  contrast  agent  to  check  the
orrect  location  on  mammograms.  Two  types  of  products  are
sed:  stains  and  radioactive  colloids.
tains  (blue,  carbon)  (Fig.  22b)
atent  blue  may  in  exceptional  cases  cause  anaphylac-
ic  shock,  which  should  mean  that  its  use  is  limited
o  establishments  ready  to  provide  emergency  treatment
f  this  type  of  complication  [9].  The  risk  is  considered
ower  with  methylene  blue,  but  the  latter  diffuses  more
apidly.
There  is  no  allergic  risk  with  carbon  (carbon  black,  India
nk).  It  does  not  diffuse  and  is  not  resorbed.  There  can  there-
ore  be  a  long  time  between  marking  and  surgery  but  if  it  is
ot  totally  removed  at  the  time  of  surgery,  a  tattoo  remains.
his  product  is  not  authorized  in  certain  countries  such  as
he  United  States  and  there  is  no  marketing  authorization
or  this  indication  in  France.
adioactive  colloids  (ROLL  or  SNOLL  technique)
he  radioisotope  cannot  be  taken  outside  the  nuclear
edicine  department.  It  is  injected  by  or  under  the  respon-ibility  of  the  nuclear  medicine  doctor.  Scintigraphy  images
re  made  30  to  120  minutes  after  injection.  If  the  sentinel
ymph  node  is  not  visible,  a new  injection  is  given  intrader-
ally  in  the  periareolar  region.
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Skin marking
Performed  in  the  surgical  position  (in  dorsal  decubitus,  the
homolateral  arm  abducted  to  90◦)  it  indicates  the  cutaneous
projection  of  the  lesion  (Fig.  22c).
Orthogonal  mammography  images  are  taken  [4,9]:  they
are  optional  in  the  case  of  colloid  injection  alone,  rec-
ommended  for  lesions  only  visible  with  ultrasound  and
systematic  in  all  other  cases  [9].  Some  surgeons  ask  for  these
images  to  be  made  with  radio-opaque  marking  of  the  nipple
(metal  bead)  and/or  of  the  skin  entry  point  (possible  with  a
wire).
The  cutaneous  point  of  entry  of  a  wire  is  ﬁxed  on  the  skin;
the  wire  is  rolled  onto  itself  and  protected  by  a  dressing.  In
no  case  must  the  wire  adhere  to  the  dressing  to  avoid  its
being  pulled  out  in  the  operating  theatre  [9].
An  oriented  radiograph  of  the  ablated  tissue  (Faxitron)  is
necessary  for  calciﬁcations  or  clips  and  it  is  sometimes  use-
ful  for  masses.  It  should  be  interpreted  whenever  possible
by  a  radiologist  [9].
Tumor destruction
Tumor  destruction  techniques  have  been  shown  to  be  effec-
tive  for  the  lungs,  liver  and  bone.  They  are  being  evaluated
for  the  breast  and  the  results  are  very  promising.
However,  surgery  remains  the  standard  technique
because  the  breast  is  a  superﬁcial  organ.  This  limits  the
consequences  of  a  surgical  approach  and  the  prognosis  for
small  tumors  operated  is  excellent.  Moreover,  percutaneous
destruction  is  only  possible  if  the  thickness  of  the  com-
pressed  breast  is  at  least  30  mm:  a  safety  margin  of  10  mm
between  the  lesion  and  the  skin  or  the  pectoral  muscle
avoids  any  burning.  Prior  percutaneous  biopsy  is  necessary  to
be  able  to  diagnose  the  indication  for  percutaneous  destruc-
tion  and  allow  suitable  management.
Destruction  is  by  heat  (hyperthermia)  or  by  cold
(cryotherapy).
The  main  complication  is  cutaneous  or  parietal  burning.
Hyperthermia
Above  60 ◦C,  proteins  coagulate,  resulting  in  cell  death.  The
temperature  is  stabilized  at  approximately  90 ◦C,  not  reach-
ing  100 ◦C  to  avoid  carbonization.
Several  techniques  are  available:  radiofrequency,
microwaves,  focused  ultrasound,  interstitial  laser,
electroporation,  etc.
Radiofrequency  is  the  oldest  technique,  the  best  known
and  the  least  expensive.  Mainly  performed  with  ultrasound
guidance,  it  uses  alternating  current,  which  creates  agita-
tion  and  ionic  friction  thus  raising  the  temperature.
The  percentage  of  necrosis  observed  varies  according  to
the  size  of  the  tumor:  from  76%  (diameter  <  40  mm)  [58]  to
100%  (<  20  mm)  [59,60].Cryotherapy
The  temperature  is  lowered  to  −160  to  −190 ◦C,  creating  an
ice-cube  at  the  end  of  the  probe.
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This  technique  has  several  advantages  over  hyperther-
ia:
it  is  not  adversely  affected  by  the  heterogeneity  of  breast
tissue  (gland  +  fat);
it is  not  painful  because  cold  acts  as  an  anaesthetic,  which
means  that  the  procedure  can  be  performed  under  local
anaesthesia;
it  is  perfectly  suitable  for  MRI  because  it  does  not  perturb
the  magnetic  ﬁeld.
he report
he  following  will  be  described  in  the  report:
the  lesion:  size,  appearance,  BI-RADS  classiﬁcation;
its  site:  clock  radius,  distance  relative  to  nipple,  depth;
implantation  and  site  of  any  marker  (clip,  wire)  relative
to  the  lesion;
guidance  method;
approach;
targeting  quality,  number  of  specimens,  their  radiological
appearance  and  of  the  lesion  after  biopsy  when  sampling
has  occurred;
any  complications;
any dose;
references  of  the  disposable  equipment  used  (needle,
wire,  clip):  brand,  description,  batch,  date  of  expiry
(Fig.  2).
The  labels  could  be  glued  into  a  ﬁle  kept  by  the  establish-
ent  where  the  procedure  was  performed,  thus  providing
ouble  traceability  [9].
ncidents and complications
t  is  essential  to  monitor  patients  to  check  the  results  and
rovide  them  with  them,  to  detect  any  discordance,  under-
stimation,  failures  and  complications.
Recording  the  various  data  from  the  examination  (the
ndication,  technique,  results  and  monitoring)  allows  you  to
valuate  your  practices,  correct  drifting  and  errors,  and  thus
mprove  the  quality  of  patient  management.
If  a  risk-carrying  situation  is  encountered  before,
uring  or  after  the  procedure,  it  can  be  declared  vol-
ntarily  under  the  process  for  accreditation  of  doctors
ith  risk-carrying  activities.  The  modalities  for  this  were
aid  down  in  two  decrees  in  2006  (no 909  and  1559)
nd  the  HAS  has  been  responsible  for  setting  it  up
www.has-sante.fr/accreditation-des-medecins) It  aims  at
mproving  practice  by  declaring  and  analyzing  certain  risk-
arrying  events  or  situations  encountered  and  by  publishing
ecommendations.
However  the  complications  encountered  in  interven-
ional  breast  imaging  are  more  often  than  not  minor.
bove  all  they  involve  bleeding  which  is  reduced  by  sim-
le  compression.  A haematoma,  usually  limited  and  well
olerated,  is  observed  in  less  than  7%  of  breast  biopsies.
Vagal  malaise,  sepsis,  burns  (tumor  destruction),  migra-
ion  or  malpositioning  of  markers  is  more  rarely  encoun-
ered,  and  sometimes  failure.
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Pneumothorax  and  surgical  revision  (bleeding,  abscess)
re  exceptional.
Cells  are  sometimes  displaced  during  these  procedures,
ut  they  would  not  be  viable.  Indeed  their  frequency  on
blated  tissue  decreases  as  the  length  of  time  from  the  pro-
edure  increases.  This  possible  tumor  seeding,  in  any  case,
ould  have  no  clinical  consequences  [61—65].
onclusion
espite  the  increase  in  incidence  of  breast  cancer,  mortal-
ty  has  declined  since  2000  (−1.3%  between  2000  and  2005)
hrough  earlier  diagnosis  and  improvements  in  treatment
1].  Management  is  best  provided  by  a  multidisciplinary
eam  composed  of  experienced  specialized  practitioners
ho  regularly  evaluate  their  practice  and  results.  Interven-
ional  procedures  contribute  greatly  to  this  structure  by
llowing  histological  diagnosis  and  accurate  localization  of
ubclinical  breast  lesions  and  providing  better  information
o  patients.  This  early  management  and  reduction  in  the
umber  of  surgical  procedures  is  helping  to  make  savings  in
he  cost  of  healthcare.
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